• In March 2026, Northrop Grumman presented at the SATELLITE Conference in Washington, D.C., showcasing its space superiority and cyber capabilities, while also advancing autonomous mission technology through its Talon IQ testbed with Shield AI’s Hivemind software.
• At the same time, Northrop Grumman’s role as a prime contractor on the Golden Dome antimissile shield underscores how its missile defense and autonomy work are becoming increasingly central to large, long-term U.S. defense programs.
• Against this backdrop, we’ll examine how Northrop Grumman’s expanding role in the Golden Dome antimissile shield reshapes its investment narrative.

Rare earth metals are the new gold rush. Find out which 26 stocks are leading the charge.

Northrop Grumman Investment Narrative Recap

To own Northrop Grumman, you need to believe that demand for advanced missile defense, space systems, and autonomy will support steady contracts despite mixed recent profitability trends. The Golden Dome antimissile shield and SATELLITE 2026 spotlight Northrop’s space and missile defense capabilities, but do not materially change the near term picture: the key catalyst remains execution on large U.S. programs such as B 21 and Sentinel, while heavy capital investment and fixed price exposure stay the biggest operational risk.

The Golden Dome program, where Northrop Grumman is a prime contractor alongside other major defense firms, ties directly into the broader catalyst of rising funding for missile defense and space based capabilities. In that context, the recent SATELLITE Conference focus on space superiority, cyber, and autonomous mission technology, including the Talon IQ and Shield AI Hivemind flight milestone, reinforces how Northrop is positioning its portfolio toward higher growth segments that could offset pressure from slower growing legacy hardware platforms.

Yet beneath the appeal of long term Golden Dome funding, investors should be aware that program delays or political shifts could...

Northrop Grumman’s narrative projects $47.5 billion revenue and $4.4 billion earnings by 2028. This requires 5.5% yearly revenue growth and about a $0.5 billion earnings increase from $3.9 billion today.

Uncover how Northrop Grumman's forecasts yield a $724.39 fair value, a 5% upside to its current price.

Exploring Other Perspectives

Two fair value estimates from the Simply Wall St Community span a wide range, from about US$514 to US$724 per share, underscoring how differently individual investors see Northrop Grumman. Set against the concentration of value in large, long term U.S. defense programs, this spread highlights why you may want to compare several views before deciding how such program risk could affect future performance.

Explore 2 other fair value estimates on Northrop Grumman - why the stock might be worth 26% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Northrop Grumman research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Northrop Grumman research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Northrop Grumman's overall financial health at a glance.

Searching For A Fresh Perspective?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Outshine the giants: these 21 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.